A heat-shocked melanoma cell lysate vaccine enhances tumor infiltration by prototypic effector T cells inhibiting tumor growth

BACKGROUND: Immune checkpoint blocker (ICB) therapy has shown survival benefits for some patients with cancer. Nevertheless, many individuals remain refractory or acquire resistance to treatment, motivating the exploration of complementary immunotherapies. Accordingly, cancer vaccines offer an attra...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Immunother Cancer
Huvudupphovsmän: Gleisner, María Alejandra, Pereda, Cristián, Tittarelli, Andrés, Navarrete, Mariela, Fuentes, Camila, Ávalos, Ignacio, Tempio, Fabian, Araya, Juan Pablo, Becker, María Inés, González, Fermín Eduardo, López, Mercedes Natalia, Salazar-Onfray, Flavio
Materialtyp: Artigo
Språk:Inglês
Publicerad: BMJ Publishing Group 2020
Ämnen:
Oncolytic and Local Immunotherapy
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7373330/
https://ncbi.nlm.nih.gov/pubmed/32690772
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-000999
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk